CCPME backs JSS Medical Research's buy of Max Neeman
JSS Medical Research Inc has bought Max Neeman International, a contract research organization (CRO) with headquarters in New Delhi, India, for an undisclosed amount. JSS, a Montréal-based CRO that offers clinical trial, health economics and outcomes research, post-marketing trial and market access solutions, said the acquisition widens its presence in the Asia-Pacific region. The deal was supported by an equity investment recently made in the company by Capital Croissance PME, a joint private equity fund of the Caisse de dépôt et placement du Québec and Capital régional et coopératif Desjardins.
4 May 2015•4 mins read
